© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Success as a CEO  in Drug Development
Posted 26th June 2017

Success as a CEO in Drug Development

Under the Business Elite Awards 2017, the exclusive CEO of the Year - Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Success as a CEO in Drug Development
Image

Under the Business Elite Awards 2017, the exclusive CEO of the Year – Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Francesco Sinigaglia is the CEO and co-founder of Anabasis, an Italian biopharmaceutical company developing Nerve Growth Factor (NGF) for severe eye diseases. In 2011, he sold Anabasis to Dompé for approximately 10 million upfront and 160 million in regulatory and commercial milestones. Francesco’s industry expertise lies in the life science, biotechnology and pharmaceutical sectors.

He starts the interview by detailing his role following the acquisition and his undoubted experience as a seasoned professional in the industry, plus his reflections on his greatest professional achievement to date.

“After the acquisition, I remained on board as COO to complete the development of the NGF. It was a great success, indeed NGF is now being approved in the EU by European Medicines Agency (EMA).

“Going back a bit, I spent more than 35 years in the biotech and pharmaceutical industry. This included 20 years at Roche, with the first 10 of these at the company’s headquarters in Basel and then as a research director in Italy. In 2002, I founded my first biotech company, Bioxell, that I took public on the Swiss Stock Exchange in 2006 and sold it to Cosmo Pharmaceutical three years later. In 2009, I founded the company Anabasis.

“My biggest achievement is the success of Anabasis, both in terms of scientific and clinical development and for the ability to create value. We financed the development programmes by ourselves and through the collaboration agreement with Dompé, thus avoiding the financial support of venture capital and consequently value dilution.”

Francesco then offers his thoughts on what makes him stand out from other CEO’s and the advice he would you give to anyone wishing to pursue the same career route.

“Drug development is a difficult and risky business. Indeed, only a very few drugs are approved each year and these are mostly from large multinational organisations. To have been able, with rather limited resources, to complete the preclinical, clinical and regulatory development and obtain approval by the regulatory authorities is indeed for me a very major achievement.

“For anybody wishing to take the same career route as me, I would underline that, if you believe that you have a good business idea, just go for it don’t be afraid to fail. It is very true to say that failure is a very important component of the learning process.”

Finally, Francesco draws our attention to another accolade he has won over the past 12 months, including the Best Biopharmaceutical Company – Italy and Excellence Award for Industrial Research 2017, as well as the Business Elite Awards 2017 CEO of the Year – Italy award that this feature interview celebrates.

Categories: Leadership


You Might Also Like
Read Full PostRead - Eye Icon
Kenya: Ensuring Economic Growth
Finance
12/10/2015Kenya: Ensuring Economic Growth

Mohammed Muigai is a leading law firm based in Kenya’s capital, Nairobi. Comprising six partners and five associates, allied to the finest legal and administrative support staff, the firm’s reputation as a market leader derives from a tradition of excellen

Read Full PostRead - Eye Icon
Boosting Business Efficiency: Innovative Solutions for Accurate Documentation and Record-Keeping
News
04/01/2024Boosting Business Efficiency: Innovative Solutions for Accurate Documentation and Record-Keeping

In today’s fast-paced business environment, efficiency is the key to success. One area where efficiency plays a crucial role is in documentation and record-keeping. Accurate and timely documentation not only ensures compliance with regulations but also e

Read Full PostRead - Eye Icon
An Influential and Global Leader
Leadership
23/01/2018An Influential and Global Leader

Studio Legale Ichino Brugnatelli e Associati (Ichino Brugnatelli) is a wide-ranging Italian law firm, holding an outstanding reputation.

Read Full PostRead - Eye Icon
Top Employee Engagement Tools for Managers: How to Keep Your Team Engaged
Leadership
26/07/2023Top Employee Engagement Tools for Managers: How to Keep Your Team Engaged

Managers bear several responsibilities, one of which is to ensure that their team remains engaged and motivated. However, keeping up with the ever-changing employee engagement needs can be challenging.

Read Full PostRead - Eye Icon
Chronos Therapeutics Acquires Pre-clinical Programmes from Shire
Leadership
20/07/2016Chronos Therapeutics Acquires Pre-clinical Programmes from Shire

Chronos Therapeutics Ltd (Chronos), the private biotech company focused on ageing diseases, brain and nervous system disorders, today announced the acquisition of three pre-clinical development programmes targeting Central Nervous System (CNS) diseases from a

Read Full PostRead - Eye Icon
Innovative Bites Acquires Hancocks
M&A
13/04/2017Innovative Bites Acquires Hancocks

Confectionery powerhouse Innovative Bites has today, Wednesday 12 April 2017, acquired Hancocks Holdings, the UK’s leading supplier of wholesale sweets, from H2 Equity Partners and management.

Read Full PostRead - Eye Icon
Mid Market Top 50
Innovation
02/06/2016Mid Market Top 50

Novimmune is a privately held Swiss bio-pharmaceutical company focused on the discovery, development and commercialisation of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.

Read Full PostRead - Eye Icon
The Telling Signs of Imposter Syndrome and How to Overcome Them
Leadership
11/03/2024The Telling Signs of Imposter Syndrome and How to Overcome Them

Feeling like a fraud in your professional life is something that many highly successful people battle with. Thoughts of not being good enough, lacking necessary experience, or simply not deserving your success are known popularly as imposter syndrome.

Read Full PostRead - Eye Icon
Building a Successful Fitness Business
News
17/05/2024Building a Successful Fitness Business

Embarking on a journey to become a professional personal trainer can be as exhilarating as it is transformative. For those aspiring to turn their passion for fitness into a lucrative career, acquiring the right credentials is a crucial step. Choosing to enrol



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow